Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women [8]

Diabetes Care

Volumn 23, Issue 3, 2000, Pages 422-424

  Lasco, Antonino ^a   Alvaro, Santo ^a   Frisina, Nicola ^a   Di Benedetto, Antonino ^a   Denuzzo, Giulia ^a   Cucinotta, Domenico ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; GESTAGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEVONORGESTREL; LIPID; LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE; PROGESTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LETTER; LIPID BLOOD LEVEL; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0034100162     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.3.422     Document Type: Letter

References (18)

1. Proudler AJ, Felton C, Stevenson JC: Ageing and the response of plasma insulin, glucose and C-peptide concentration to intravenous glucose in postmenopausal women. Clin Sci 83:489-494, 1992
2. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC: The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese healthy women. Eur J Clin Invest 23:466-473, 1993
3. Godsland IF, Rosano GMC, Proudler AJ. Collins P, Poole-Wilson P, Stevenson JC: Insulin resistance in postmenopausal women with syndrome X who do not respond to estrogen therapy, Circulation 90:550-554, 1994
4. Stevenson JC, Crook D, Godsland IF: Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 98:83-90, 1993
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-965, 1993
7. McFarland KF, Boniface ME, Hornung CA, Earnhardt W, Humphries JON: Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J 117:1209-1214, 1989
8. Falkeborn M, Persson I. Adami HO, Bergstrom R, Eaker E, Lithell H, Mohsen R, Naesen R: The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 99:821-828, 1992
9. Applebaum-Bowden D, McLean P, Steinmetz A, Fontana D. Matthys C, Warnick GR, Cheung M, Albers JJ, Azzard WR: Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res 30:1895-1906, 1989
10. Morjani S, Dupont A, Labrie F, Delignierer B, Cusan L, Dupont P, Mailloux J, Lupien PJ: Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women. J Clin Endocrinol Metab 73:373-379, 1991
11. Godsland IF: Hormone replacement therapy and insulin resistance. Menopause Rev 2:21-27, 1997
12. Godsland IF, Gangar K, Walton C, Cust MP, Whitehead MI, Wynn V, Stevenson JC: Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 42:846-853, 1993
13. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser, no. 727)
14. De Fronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (Suppl. 3):E214-E223, 1979
15. Lasco A, Cucinotta D, Gigante A, Denuzzo G, Pedullà M, Trifiletti A, Frisina N: No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide. Eur J Endocrinol 133:718-722, 1995
16. Friedewald WT, Levy R, Fredrickson DJ: Estimation of serum low density lipoprotein without use of preparative ultracentrifuge. Ann Chem 18:499-502, 1972
17. Whitcroft SI, Crook D, Marsh MS: Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet Gynecol 84:222-226, 1994
18. Stevenson JC: Hormone replacement therapy and lipids. Menopause Rev 2:15-20, 1997